{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:01:06Z","timestamp":1791928866724,"version":"4.3.4"},"reference-count":31,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"6","license":[{"start":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T00:00:00Z","timestamp":1749600000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest. Ophthalmol. Vis. Sci."],"published-print":{"date-parts":[[2025,6,11]]},"DOI":"10.1167\/iovs.66.6.38","type":"journal-article","created":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T10:30:35Z","timestamp":1749637835000},"page":"38","source":"Crossref","is-referenced-by-count":8,"title":["Investigating the Immunogenic Potential of Variations in Host Cell Protein Levels in Clinical-Grade AAV8 Products"],"prefix":"10.1167","volume":"66","author":[{"given":"Immanuel P.","family":"Seitz","sequence":"first","affiliation":[{"name":"Centre for Ophthalmology, University Hospital T\u00fcbingen, T\u00fcbingen, Germany"},{"name":"Oxford Eye Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom"},{"name":"Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Rodr\u00edguez-Bocanegra","sequence":"additional","affiliation":[{"name":"Centre for Ophthalmology, University Hospital T\u00fcbingen, T\u00fcbingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten","family":"Bucher","sequence":"additional","affiliation":[{"name":"Centre for Ophthalmology, University Hospital T\u00fcbingen, T\u00fcbingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix F.","family":"Reichel","sequence":"additional","affiliation":[{"name":"Centre for Ophthalmology, University Hospital T\u00fcbingen, T\u00fcbingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stylianos","family":"Michalakis","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University Hospital, LMU Munich, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitri","family":"Romanovsky","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University Hospital, LMU Munich, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Biel","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Center for Drug Research, Ludwig-Maximilians-University of Munich, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Wissinger","sequence":"additional","affiliation":[{"name":"Centre for Ophthalmology, University Hospital T\u00fcbingen, T\u00fcbingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl-Ulrich","family":"Bartz-Schmidt","sequence":"additional","affiliation":[{"name":"Centre for Ophthalmology, University Hospital T\u00fcbingen, T\u00fcbingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Peters","sequence":"additional","affiliation":[{"name":"Centre for Ophthalmology, University Hospital T\u00fcbingen, T\u00fcbingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel D.","family":"Fischer","sequence":"additional","affiliation":[{"name":"Centre for Ophthalmology, University Hospital T\u00fcbingen, T\u00fcbingen, Germany"},{"name":"Oxford Eye Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom"},{"name":"Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the RD-CURE Consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27","reference":[{"issue":"7","key":"bib1","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1167\/iovs.64.7.39","article-title":"Gene therapy for retinal degenerative diseases: progress, challenges, and future directions","volume":"64","author":"Drag","year":"2023","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"bib2","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.oret.2021.03.016","article-title":"Perifoveal chorioretinal atrophy after subretinal voretigene neparvovec-rzyl for RPE65-mediated Leber congenital amaurosis","volume":"6","author":"Gange","year":"2022","journal-title":"Ophthalmol Retina"},{"issue":"9","key":"bib3","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1136\/bjophthalmol-2021-321023","article-title":"Development of retinal atrophy after subretinal gene therapy with voretigene neparvovec","volume":"107","author":"Reichel","year":"2023","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"bib4","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.oret.2023.08.017","article-title":"Classification and growth rate of chorioretinal atrophy after voretigene neparvovec-rzyl for RPE65-mediated retinal degeneration","volume":"8","author":"Bommakanti","year":"2024","journal-title":"Ophthalmol Retina"},{"issue":"7","key":"bib5","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.ophtha.2023.02.015","article-title":"Full-field scotopic threshold improvement after voretigene neparvovec-rzyl treatment correlates with chorioretinal atrophy","volume":"130","author":"Stingl","year":"2023","journal-title":"Ophthalmology"},{"issue":"2","key":"bib6","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1167\/tvst.13.2.13","article-title":"Chorioretinal atrophy growth after voretigene neparvovec retinotopically is connected to retinal functional rescue","volume":"13","author":"Stingl","year":"2024","journal-title":"Transl Vis Sci Technol"},{"issue":"11","key":"bib7","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1016\/j.ophtha.2022.06.018","article-title":"Inflammation after voretigene neparvovec administration in patients with RPE65-related retinal dystrophy","volume":"129","author":"Kessel","year":"2022","journal-title":"Ophthalmology"},{"key":"bib8","doi-asserted-by":"publisher","first-page":"100516","DOI":"10.1016\/j.xops.2024.100516","article-title":"Dose-dependent progression of chorioretinal atrophy at the injection site after subretinal injection of rAAV2\/8 in non-human primates","volume":"4","author":"Seitz","year":"2024","journal-title":"Ophthalmol Sci"},{"issue":"580","key":"bib9","doi-asserted-by":"publisher","first-page":"eabd3438","DOI":"10.1126\/scitranslmed.abd3438","article-title":"Engineering adeno-associated viral vectors to evade innate immune and inflammatory responses","volume":"13","author":"Chan","year":"2021","journal-title":"Sci Transl Med"},{"key":"bib10","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1089\/hum.2023.194","article-title":"Complement system response to adeno-associated virus vector gene therapy","volume":"35","author":"Kropf","year":"2024","journal-title":"Hum Gene Ther"},{"issue":"2","key":"bib11","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.ymthe.2023.11.029","article-title":"TLR9-independent CD8(+) T cell responses in hepatic AAV gene transfer through IL-1R1-MyD88 signaling","volume":"32","author":"Kumar","year":"2024","journal-title":"Mol Ther"},{"issue":"1","key":"bib12","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3390\/biomedicines2010080","article-title":"Product-related impurities in clinical-grade recombinant AAV vectors: characterization and risk assessment","volume":"2","author":"Wright","year":"2014","journal-title":"Biomedicines"},{"issue":"1","key":"bib13","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1038\/s41598-023-28830-7","article-title":"Extra-viral DNA in adeno-associated viral vector preparations induces TLR9-dependent innate immune responses in human plasmacytoid dendritic cells","volume":"13","author":"Bucher","year":"2023","journal-title":"Sci Rep"},{"key":"bib14","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1089\/hum.2023.188","article-title":"Pre-existing immunity to a nucleic acid contaminant-derived antigen mediates transaminitis and resultant diminished transgene expression in a mouse model of hepatic rAAV-mediated gene transfer","volume":"35","author":"Brimble","year":"2024","journal-title":"Hum Gene Ther"},{"key":"bib15","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.omtm.2020.05.018","article-title":"Methods matter: standard production platforms for recombinant AAV produce chemically and functionally distinct vectors","volume":"18","author":"Rumachik","year":"2020","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"4","key":"bib16","doi-asserted-by":"publisher","first-page":"101383","DOI":"10.1016\/j.omtm.2024.101383","article-title":"Quantitative proteomic analysis of residual host cell protein retention across adeno-associated virus affinity chromatography","volume":"32","author":"Leibiger","year":"2024","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"24","key":"bib17","doi-asserted-by":"publisher","first-page":"3184","DOI":"10.1182\/blood-2016-11-751040","article-title":"Plasmacytoid and conventional dendritic cells cooperate in crosspriming AAV capsid-specific CD8(+) T cells","volume":"129","author":"Rogers","year":"2017","journal-title":"Blood"},{"issue":"8","key":"bib18","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.1172\/JCI37607","article-title":"The TLR9-MyD88 pathway is critical for adaptive immune responses to adeno-associated virus gene therapy vectors in mice","volume":"119","author":"Zhu","year":"2009","journal-title":"J Clin Invest"},{"issue":"6","key":"bib19","doi-asserted-by":"publisher","first-page":"2727","DOI":"10.1128\/JVI.01990-07","article-title":"Complement is an essential component of the immune response to adeno-associated virus vectors","volume":"82","author":"Zaiss","year":"2008","journal-title":"J Virol"},{"issue":"24","key":"bib20","doi-asserted-by":"publisher","first-page":"19928","DOI":"10.18632\/oncotarget.4562","article-title":"A new \"sweet\" ligand for Toll-like receptor 4","volume":"6","author":"Deierborg","year":"2015","journal-title":"Oncotarget"},{"issue":"9","key":"bib21","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1074\/mcp.M500061-MCP200","article-title":"Exponentially modified protein abundance index (emPAI) for estimation of absolute protein amount in proteomics by the number of sequenced peptides per protein","volume":"4","author":"Ishihama","year":"2005","journal-title":"Mol Cell Proteomics"},{"issue":"1","key":"bib22","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1167\/tvst.14.1.29","article-title":"Ocular safety and toxicology of subretinal gene therapy with rAAV.hPDE6A in nonhuman primates","volume":"14","author":"Seitz","year":"2025","journal-title":"Transl Vis Sci Technol"},{"issue":"11","key":"bib23","doi-asserted-by":"publisher","first-page":"644","DOI":"10.3390\/v10110644","article-title":"Site-specific N-glycosylation on the AAV8 capsid protein","volume":"10","author":"Aloor","year":"2018","journal-title":"Viruses"},{"issue":"12","key":"bib24","doi-asserted-by":"publisher","first-page":"6620","DOI":"10.1128\/JVI.00297-12","article-title":"Human galectin 3 binding protein interacts with recombinant adeno-associated virus type 6","volume":"86","author":"Denard","year":"2012","journal-title":"J Virol"},{"key":"bib25","doi-asserted-by":"publisher","first-page":"14031","DOI":"10.1038\/mtm.2014.31","article-title":"Different protein composition and functional properties of adeno-associated virus-6 vector manufactured from the culture medium and cell lysates","volume":"1","author":"Denard","year":"2014","journal-title":"Mol Ther Methods Clin Dev"},{"key":"bib26","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.omtm.2018.08.001","article-title":"AAV-8 and AAV-9 vectors cooperate with serum proteins differently than AAV-1 and AAV-6","volume":"10","author":"Denard","year":"2018","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"8","key":"bib27","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1096\/fj.01-0995fje","article-title":"Preferential transformation of human neuronal cells by human adenoviruses and the origin of HEK 293 cells","volume":"16","author":"Shaw","year":"2002","journal-title":"Faseb J"},{"issue":"3","key":"bib28","doi-asserted-by":"publisher","first-page":"M111.014050","DOI":"10.1074\/mcp.M111.014050","article-title":"Comparative proteomic analysis of eleven common cell lines reveals ubiquitous but varying expression of most proteins","volume":"11","author":"Geiger","year":"2012","journal-title":"Mol Cell Proteomics"},{"issue":"6","key":"bib29","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.3892\/ijmm.2016.2568","article-title":"293 cells express both epithelial as well as mesenchymal cell adhesion molecules","volume":"37","author":"Inada","year":"2016","journal-title":"Int J Mol Med"},{"key":"bib30","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.omtm.2021.12.006","article-title":"Comparison of highly pure rAAV9 vector stocks produced in suspension by PEI transfection or HSV infection reveals striking quantitative and qualitative differences","volume":"24","author":"Trivedi","year":"2022","journal-title":"Mol Ther Methods Clin Dev"},{"key":"bib31","doi-asserted-by":"publisher","first-page":"116009","DOI":"10.1016\/j.jpba.2024.116009","article-title":"A simple and sensitive differential digestion method to analyze adeno-associated virus residual host cell proteins by LC-MS","volume":"242","author":"Hu","year":"2024","journal-title":"J Pharm Biomed Anal"}],"container-title":["Investigative Ophthalmology & Visual Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/iovs.arvojournals.org\/article.aspx?articleid=2803121","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:32:04Z","timestamp":1791927124000},"score":1,"resource":{"primary":{"URL":"https:\/\/iovs.arvojournals.org\/article.aspx?articleid=2803121"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,11]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6,2]]}},"URL":"https:\/\/doi.org\/10.1167\/iovs.66.6.38","relation":{},"ISSN":["1552-5783"],"issn-type":[{"value":"1552-5783","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6,11]]}}}